Correlation Between Candel Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Candel Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for Candel Therapeutics and Pasithea Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Candel and Pasithea is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Candel Therapeutics is 1.63 times less risky than Pasithea Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 560.00 in Pasithea Therapeutics Corp on September 5, 2024 and sell it today you would lose (269.00) from holding Pasithea Therapeutics Corp or give up 48.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Candel Therapeutics |
| Pasithea Therapeutics |
Candel Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite Candel Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Pasithea Therapeutics vs. Candel Therapeutics | Pasithea Therapeutics vs. Cingulate Warrants | Pasithea Therapeutics vs. Unicycive Therapeutics | Pasithea Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |